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T

he mechanism by which substrates for endoplasmic
reticulum–associated degradation are retrotranslocated to the cytosol remains largely unknown, although ubiquitination is known to play a key role. The
mouse γ-herpesvirus protein mK3 is a viral RING-CH–type
E3 ligase that speciﬁcally targets nascent major histocompatibility complex I heavy chain (HC) for degradation,
thus blocking the immune detection of virus-infected cells.
To address the question of how HC is retrotranslocated

and what role mK3 ligase plays in this action, we investigated ubiquitin conjugation sites on HC using mutagenesis
and biochemistry approaches. In total, our data demonstrate that mK3-mediated ubiquitination can occur via
serine, threonine, or lysine residues on the HC tail, each of
which is sufﬁcient to induce the rapid degradation of HC.
Given that mK3 has numerous cellular and viral homologues, it will be of considerable interest to determine the
pervasiveness of this novel mechanism of ubiquitination.

Introduction
ER-associated degradation (ERAD) is an important component of ER quality control whereby unwanted proteins that are
misfolded, misassembled, or metabolically excessive are recognized and returned to the cytosol by a process called retrotranslocation or dislocation (Hampton, 2002; Jarosch et al.,
2002a; Tsai et al., 2002; Meusser et al., 2005). Once exposed to
the cytosol, ERAD-targeted proteins are ubiquitinated and subsequently degraded by the cytosolic proteasome. The fact that
dysfunction in ERAD causes human diseases (McCracken and
Brodsky, 2003) and many viral proteins hijack this pathway to
evade detection by the immune system (Ploegh, 1998; Lybarger
et al., 2005) highlights its importance.
Since ERAD was first appreciated over a decade ago, several key players have been identified, particularly from a study
of yeast (Meusser et al., 2005). However, our knowledge of how
ERAD substrates are specifically recognized and extracted from
the ER lumen remains incomplete. Highly relevant to this question, recent studies have demonstrated that distinct protein complexes are formed at the ER membrane that are involved in the
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recognition, ubiquitination, and extraction of specific substrate
classes (Carvalho et al., 2006; Denic et al., 2006). Although
only a few have been implicated in ERAD, ubiquitin (Ub) E3
ligases clearly play a central role in the organization of different
ER membrane complexes involved in ERAD of distinct substrate classes. For example, yeast E3 ligase Hrd1p/Der3p is a
key component of a core membrane complex that processes
substrates with lumenal lesions, the so-called ERAD-L pathway.
This core complex includes membrane protein Hrd3p (Vashist
and Ng, 2004; Carvalho et al., 2006; Denic et al., 2006) that recruits lumenal folding sensor Yos9p (Bhamidipati et al., 2005;
Kim et al., 2005) as well as the membrane protein Ubx2p
that recruits the cytosolic cdc48 ATPase complex (Schuberth
and Buchberger, 2005). On the other hand, Doa10p, another
well-characterized yeast E3 ligase implicated in ERAD, is a
key and central component of a core membrane complex that
processes ERAD substrates with lesions in their cytoplasmic
domains, a so-called ERAD-C pathway (Vashist and Ng, 2004;
Carvalho et al., 2006). This Doa10p complex includes Ubc7
and its membrane anchor Cue1 as well as cdc48 and its cofactors. However, the specific factors that are capable of recognizing the defect in the cytoplasmic tail of a substrate have not
been defined. Nevertheless, substrate ubiquitination as specifically rendered by the E3 ligase is required for both pathways to
completely remove the ERAD target from the ER by the cdc48
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Figure 1. The K residues of MHC class I HC are dispensable
for mK3-mediated HC down-regulation. (A) The structure of
the ectodomain of Ld was generated using published coordinates of the Ld–p29 complex (Protein Data Bank 1LD9). There
are a total of 12 K residues on the Ld molecule: the three on
the cytoplasmic tail are K308, K316, and K337, and the nine
on the ectodomain are shown in the structure. Of the nine, six
conserved Ks are underlined, and the other three (K31, K173,
and K196) are unique to Ld. (B) WT3 cells expressing wildtype (wt) or K-less Ld were cotransduced with one of the following constructs: pMIG only (vector), pMIG.mK3 (mK3), or
pMIG.mK3 C48G, C51G (an mK3 RING-CH domain mutant
named mK3 RING mut). Flow cytometric analysis of surface Ld
expression (detected by 30-5-7 staining) versus GFP ﬂuorescence is shown. The number in each plot represents the ratio
of Ld staining intensities between GFP+ and GFP− populations. (C) Cells used in B were enriched by sorting the GFP+
fraction of the transduced cell line. These enriched cells were
incubated for 24 h with 125 U/ml IFN-γ, pulse labeled with
[35S]Cys/Met, and chased for the indicated times with unlabeled Cys/Met. Ld precipitates were resolved by SDS-PAGE
and visualized by autoradiography. Ld and β2m bands are
indicated (left). In the right panel, relative band intensities
from the gels are plotted as a percentage of the intensity at
time zero for each cell line.
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Whether they are responsible for distinct subsets of ERAD substrates or share the same substrates is not yet clear. Furthermore,
multiple lines of evidence indicate that US2 and US11, two human cytomegalovirus-encoded immune evasion proteins, use
distinct ERAD pathways to target HC for ERAD (Lilley and
Ploegh, 2005; Hassink et al., 2006). However, neither HRD1
nor gp78 is required for US2- or US11-induced ERAD, suggesting that they may recruit novel E3s (Lilley and Ploegh,
2005; Ye et al., 2005). Collectively, these findings clearly suggest that mammals have evolved very specific and highly regulated ERAD pathways servicing distinct substrates.
Immune evasion protein mK3 is a viral E3 ligase encoded
by mouse γ-herpesvirus 68 (Virgin et al., 1997). It was previously
shown that mK3 specifically targets nascent HC for rapid
degradation in an ubiquitination-proteasome–dependent manner
(Boname and Stevenson, 2001; Yu et al., 2002). The RING-CH
domain presumably conferring mK3 ligase activity is highly
conserved among members of the K3 family, which includes a
group of viral proteins encoded by herpesviruses and poxviruses
(Coscoy and Ganem, 2003; Lehner et al., 2005). Cellular K3
homologues have also been detected, although their physiological
function remains to be defined (Lehner et al., 2005). Interestingly,
one of the cellular K3 homologues in human named MARCH VI
(TEB4) has been recently identified as a homologue of Doa10p
based on its ER localization and conserved cytosolic RING-CH
domain with E3 ligase activity (Bartee et al., 2004; Hassink et al.,
2005; Kreft et al., 2006). However, whether MARCH VI is a
functional homologue of Doa10p remains to be determined.
We previously demonstrated that the specific recognition
of HC by mK3 required its association with transporter associated with antigen processing (TAP; Yu et al., 2002; Lybarger
et al., 2003), a transporter of peptides into the ER lumen (Pamer
and Cresswell, 1998). mK3 is also physically associated with
p97 and Derlin1, suggesting that mK3 exploits a physiological
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ATPase complex (Biederer et al., 1997; Jarosch et al., 2002b;
Flierman et al., 2003). Within this basic framework of how different substrates are targeted for ERAD, several critical questions remain. For example, in the context of each pathway,
(1) how do E3 ligases impose substrate specificity, and (2) at
which step of ERAD does substrate ubiquitination occur?
Whether different pathways defined in yeast such as the
ERAD-L and ERAD-C pathways are conserved in mammals is
not well established. However, the fact that most components of
ERAD defined in yeast have functional homologues in mammals
suggests evolutionary conservation. In agreement with this hypothesis, ER membrane core complexes, including E3 ligases that
link ERAD substrates to ubiquitination and extraction machinery,
have been defined in human cell studies (Lilley and Ploegh, 2005;
Ye et al., 2005). However, the mammalian ERAD mechanism is
clearly more complex. For example, three Der1p homologues
have been defined in mammals, which are designated as Derlin1,
2, and 3. Derlin1 but not Derlin2 plays a central role in ERAD of
major histocompatibility complex (MHC) class I heavy chain
(HC) by human cytomegalovirus protein US11 (Lilley and Ploegh,
2004; Ye et al., 2004). In contrast, both Derlin2 and 3 are associated with EDEM (ER degradation–enhancing α-mannosidase–
like protein) and p97 (cdc48 in yeast) and are functionally required
for ERAD of NHK (null Hong Kong), a misfolded glycosylated
luminal protein in the ER (Oda et al., 2006).
Higher eukaryotic cells presumably have many additional
E3 ligases participating in ERAD compared with yeast. For example, mammals have a homologue of the yeast RING-H2–type
E3 ligase Hrd1p called HRD-1 (Kaneko et al., 2002; Nadav
et al., 2003; Kikkert et al., 2004). However, mammals have an
additional RING-H2–type E3 ligase not found in yeast called
gp78 (Fang et al., 2001; Liang et al., 2003). Interestingly, both
HRD1 and gp78 are found in the same multiprotein ER membrane complex containing Derlin1 and p97 (Ye et al., 2005).
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be mK3 regulated. The results were unequivocal and unexpected.
None of the individual mutations, groups of mutations, or even
totally K-less Ld were found to have a substantial impact on
mK3-mediated HC down-regulation (unpublished data). For
example, in the presence of mK3, surface K-less Ld was reduced >25-fold (Fig. 1 B) and rapidly degraded with kinetics
similar to wild-type (wt) Ld (Fig. 1 C). Thus, mK3 down-regulation
of HC is clearly not compromised by the absence of K residues
in the substrate.
Down-regulation of K-less HC requires
the Ub–proteasome pathway

To establish physiological relevance, we next tested whether the
degradation of K-less HC was also dependent on Ub conjugation
and proteasome activity. As expected, the surface down-regulation
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ERAD pathway (Wang et al., 2006). Curiously, polyubiquitinated HCs detected in the presence of mK3 were membrane
bound, but lysine (K) residues in the HC tail were not required for
mK3-induced degradation (Wang et al., 2005). Based on these
observations and similar findings with other ERAD substrates,
a partial dislocation model was proposed whereby ectodomain
residues of the substrate are ubiquitinated after exposure to the
cytosol (Meusser and Sommer, 2004; Hassink et al., 2006).
Recent findings also mandated that N-terminal or non-K forms
of ubiquitination be considered (for review see Ciechanover and
Ben Saadon, 2004; Cadwell and Coscoy, 2005).
In this study, we present unequivocal evidence that the cytoplasmic tail of HC is directly ubiquitinated in the presence of
mK3 and that S or T residues are sufficient to induce the ubiquitination and rapid degradation of HC. These findings implicate
a novel chemical mechanism of substrate ubiquitination via
ester linkages. Mechanistically, our findings demonstrate that
mK3-induced ubiquitination does not require partial dislocation
of the N terminus of HC. Alternatively, our data support a model
whereby mK3 substrates are dislocated via their C terminus
after tail ubiquitination. These combined observations explain
how the mK3 ligase can function as a central component of a
core ER membrane complex constructed for the specific targeting
of HC for ERAD.

Results
mK3-mediated MHC class I ubiquitination
and rapid degradation are independent
of lumenal Ks

How ERAD substrates, especially ER membrane proteins, are
extracted from the ER membrane remains elusive, although it
has been known for a long time that ubiquitination of substrates
is pivotal. We previously demonstrated that mK3 induces polyubiquitination and rapid degradation of HC with K-less tails
(Wang et al., 2005). Given the fact that all of the functional
ubiquitination components or domains, including mK3, are located outside of the ER, this finding and similar findings with
other ERAD substrates (Shamu et al., 1999; Yu and Kopito,
1999; Meusser and Sommer, 2004) raised the possibility that
K residues in the HC ectodomain were being ubiquitinated. The
presumption is that ERAD substrates can be partially dislocated
to the cytosol before ubiquitination. If this is the case for mK3induced ERAD of HC, identifying which K residues in the
ectodomain of HC are ubiquitinated would lend strong support
to a partial dislocation model.
To determine whether and which K residues on the HC are
required for ubiquitination, we took a mutagenesis approach
using Ld as a prototypic MHC class I HC. As shown in Fig. 1 A,
a total of nine Ks were replaced by arginines (Rs) singly or in
groups based on HC domain structure. Because our previous
study had shown that tail Ks were dispensable for mK3-mediated
Ub conjugation and rapid degradation of HC (Wang et al.,
2005), all ectodomain K mutations were introduced on a K-less
tail template. Surface expression and TAP association were
confirmed for all mutants to rule out gross misfolding. We next
coexpressed each Ld K mutant with mK3 to test its capacity to

Figure 2. Down-regulation of completely K-less Ld is ubiquitinationproteasome dependent. (A) Ld HCs were immunoprecipitated with mAbs
(30-5-7 and 64-3-7) from NP-40 lysates of the cell lines used in Fig. 1 B.
Precipitates with or without endo H treatment were separated by SDSPAGE and blotted for Ub and Ld HC. In the right panel, the β-actin blot was
included as a loading control. (B) After incubation for 2 h with 5 μM/ml of
the proteasome inhibitor (PI) clasto-lactacystin β-lactone, cells expressing
wt Ld or K-less Ld (±mK3) were harvested and NP-40 lysed. Ld HCs were
precipitated, treated, or mock treated with endo H and were blotted with
the indicated antibodies. (C) Lysates from B were blotted for mK3 (rabbit
anti-mK3). The β-actin blot was included to control for equal loading.
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Fusion of a Ub moiety on the N terminus
of HC does not induce ERAD of HC in the
absence of mK3

To test the likelihood and consequences of the N-terminal ubiquitination of HC by mK3, four different Ub/HC fusion proteins

Figure 3. Ubiquitination and degradation of Ub/Ld fusion
proteins in the presence of mK3. (A) After incubation for 24 h
with 125 U/ml IFN-γ, WT3 cells expressing Ub wt/Ld K-less
or Ub K-less/Ld K-less (±mK3) were pulse labeled with
[35S]Cys/Met for 15 min and chased for the indicated times.
Ub/Ld fusion molecules were precipitated by anti-Ld mAbs.
Precipitates then were resolved by SDS-PAGE and visualized
by autoradiography (left). Relative band intensities from these
gels were plotted as a percentage of the intensity at time zero
for each line (right). (B) Cells used in A were Dounce homogenized. The homogenate was then subjected to serial centrifugations from 1,000 to 100,000 g. After digestion (or mock
digestion) with 10 μg/ml proteinase K for 20 min on ice,
Ub/Ld molecules were precipitated from NP-40 lysates of
100,000 g pellet (P) or supernatant (S) and analyzed by
immunoblotting using anti-Ub mAb or rabbit anti-Ld cytoplasmic
tail (cyt tail) antibodies. Polyubiquitinated forms are indicated
by asterisks.
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were made. More specifically, fusion proteins with either a wt
or K-less Ub moiety were attached to the N terminus of either
wt or K-less Ld. For these fusion proteins, the G76 residue of
Ub was replaced with valine to avoid detection by deubiquitinating enzymes (Johnson et al., 1995; Baker, 1996; Dantuma
et al., 2000). When expressed in WT3 cells, these fusion proteins (1) were glycosylated with N-linked endoglycosidase H
(endo H)–sensitive glycans, (2) assembled normally with β2m,
and (3) attained native class I folding based on their detection
with conformation-dependent mAb. Thus, these fusion proteins
clearly have the appropriate topology in the ER. Our rationale
for this approach was the prediction that adding a K-less Ub
to the N terminus might be unfavorable for polyubiquitination
and ERAD based on the findings that the addition of large
N-terminal tags (e.g., 6× myc or GFP) to the substrate prevented
the degradation of proteins known to be capable of N-terminal
ubiquitination (Ciechanover, 2005). Alternatively, fusion of a
wt Ub moiety on HC might facilitate ERAD because it should
be readily polyubiquitinated if or when it gains access to the
cytosol. The rationale of making fusion proteins with K-less Ld
as well as wt Ld was to determine whether the removal of Ks
might promote N-terminal ubiquitination.
To test these possible scenarios, a pulse-chase experiment
was conducted with cells expressing each of the four different
fusion proteins to compare their relative stability in the presence
or absence of mK3. As shown in Fig. 3 A, in the absence of
mK3, both wt and K-less Ub/Ld fusion proteins were quite stable throughout the chase time (lanes 1–4; and not depicted).
This demonstrates that N-terminal ubiquitination of HC alone is
not sufficient to trigger a rapid degradation. A likely explanation
is that the N terminus of HC does not gain access to the cytosol
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and the polyubiquitination of K-less Ld were both detected only
in the presence of wt mK3 but not the RING mutant (C48G,
C51G mutations in its RING-CH domain; Figs. 1 B and 2 A,
respectively). More importantly, the appearance of polyubiquitinated forms of K-less Ld in the presence of mK3 correlated
with a lower steady-state level of unconjugated molecules. In
contrast, in cells expressing the mK3 RING mutant, K-less Ld
molecules were not Ub conjugated and were dramatically stabilized (Fig. 2 A). Thus, similar to wt Ld, down-regulation of
K-less Ld was dependent on the polyubiquitination of HC facilitated by mK3. Moreover, compared with wt Ld, K-less Ld showed
a strikingly similar pattern of ubiquitination (Fig. 2 B, lanes 9–12
vs. lanes 3–6). When treated with proteasome inhibitor, the
polyubiquitinated conjugates of K-less Ld accumulated (Fig.
2 B, top; lanes 10 and 12 vs. lanes 9 and 11, respectively), and
unconjugated K-less Ld was stabilized in cells expressing mK3
(Fig. 2 B, bottom; lanes 10 and 12 vs. lanes 9 and 11, respectively).
These combined findings demonstrate that degradation of K-less
HC, like wt HC, is ubiquitination and proteasome dependent.
The implication of the aforementioned findings is that there
must be sites other than the ε-NH2 group of K on HC for mK3induced ubiquitination. As recently reviewed, a few recent studies have suggested that the first Ub moiety can be fused linearly
to the α-NH2 group on the N-terminal residue of select substrates
(for review see Ciechanover and Ben Saadon, 2004).
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The cytoplasmic tail of HC is the site
of Ub conjugation mediated by mK3

To rule out the possibility that the fusion proteins used an alternative pathway, a similar experiment was conducted with cells
expressing either wt or K-less Ld. Again, we observed that polyUb forms of both wt and K-less Ld are ER membrane associated
and disappear when the HC tail is removed (Fig. 4 A and not
depicted), suggesting that for both Ub/Ld fusion protein and wt Ld,
the cytoplasmic tail is the site of Ub conjugation. Although we

considered it unlikely, the possibility remained that proteinase K
was removing poly-Ub from the N terminus of Ld or Ub/Ld
that occurred after partial dislocation to the cytosol. If this was
the case, the cytoplasmic tail would not have to be the site of
ubiquitination. To further demonstrate that the tail is the site of
ubiquitination, a thrombin (TMB) cleavage site, LVPRGG, was
engineered into the tail of Ld right after the basic cluster
KRRRNT proximal to the transmembrane domain. The K residue in this basic cluster was replaced by R. This molecule
(Ld TMB) was normally glycosylated, β2m assembled, and
folded when expressed in WT3 cells (unpublished data). In the
presence of mK3, Ld TMB molecules were polyubiquitinated in
a pattern similar to Ld (Fig. 4 B).
Lysates from cells expressing mK3 and wt Ld or Ld TMB
were immunoprecipitated with antibodies specific for the lumenal
domain of Ld followed by TMB treatment. As expected, in the
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in the absence of mK3. However, in the presence of mK3, both
wt Ub and K-less Ub/Ld fusion proteins were rapidly degraded
(Fig. 3 A, lanes 5–8; and not depicted). More strikingly, all
of these fusion proteins displayed similar ubiquitination patterns in cells with mK3 (unpublished data). These results argue
against an N-terminal Ub conjugation. However, how these
fusion proteins were polyubiquitinated, especially the one
with K-less Ub fused to K-less Ld, remained unknown.
To solve this puzzle, a proteinase K assay was adopted to
determine the site of the polyubiquitinated portion of completely K-less Ub/Ld fusion proteins. It was formally possible
that the N terminus of K-less Ub/K-less Ld was polyubiquitinated after partial dislocation. If this was the case, the cytosolicexposed N termini of fusion proteins as well as their poly-Ub
forms would be sensitive to proteinase K digestion. To test
this possibility, the ER fraction from cells expressing K-less
Ub/K-less Ld was isolated by ultracentrifugation. The isolated
ER fraction was then subjected to proteinase K digestion followed by immunoprecipitation of HC and blotting for Ub. As
expected, Ub/Ld fusion HCs were observed only in the pellet
fraction but not in the supernatant (Fig. 3 B), indicating that the
Ub/Ld fusion protein is ER membrane bound, thus validating
the ER isolation. Again, the poly-Ub bands were observed associated with HC precipitates in mK3-expressing cells but not in
the cells without mK3 (Fig. 3 B, top; lanes 9 and 10 vs. lanes 3
and 4; poly-Ub forms are demarcated with asterisks). Also as
expected, the polyubiquitinated and unconjugated HC bands
were comparably sensitive to endo H, demonstrating that mK3
was modifying ER membrane–bound newly synthesized fusion
proteins (Fig. 3 B, lane 10 vs. lane 9).
Upon digestion of the membrane fraction by proteinase K,
domains exposed to the cytosol should be cleaved. Indeed, when
treated with proteinase K, the K-less Ub/K-less Ld fusion
protein was slightly reduced in size, resulting in a faster gel migration (Fig. 3 B, Ub blot; lanes 5 and 6 vs. lanes 3 and 4 and
lanes 11 and 12 vs. lanes 9 and 10, respectively). Furthermore,
the proteinase K–treated fusion protein was only detected by an
antibody against Ub but not by an antibody to the Ld cytoplasmic
tail (Fig. 3 B, lanes 11 and 12). Thus, proteinase K cleaved the
HC tail of the fusion protein, demonstrating that it was in the
cytosol, whereas the N-terminal Ub moiety was undisturbed,
suggesting that it resided in the lumen. More strikingly, the
poly-Ub conjugation bands also disappeared when the tail was
cleaved by proteinase K (Fig. 3 B, Ub blot; lanes 11 and 12 vs.
lanes 9 and 10), suggesting that the cytoplasmic tail of Ub/Ld
fusion protein is the site of poly-Ub chain formation induced
by mK3.

Figure 4. Polyubiquitinated Ld HCs were no longer detectable when the
cytoplasmic tail of HC was removed. (A) Similar procedures as described
in Fig. 3 B were used for analysis of the cells expressing wt Ld (±mK3). Precipitates of Ld HCs were immunoblotted by anti-Ub mAb, anti-Ld lumenal
mAbs (64-3-7), and anti-Ld cytoplasmic tail antibodies. Polyubiquitinated
forms are indicated by asterisks. (B) Ld HCs were precipitated from NP-40
lysates of the cells coexpressing mK3 and wt Ld or mK3 and Ld TMB (wt Ld
with a K308R mutation and an engineered TMB cleavage site in its cytoplasmic tail; the tail sequence of this molecule is VMRRRRNTLVPRGGKGGDYALAPGSQSSEMSLRDCKA, with the TMB cleavage site in bold). After
incubation with TMB at room temperature for 3 h and then at 4°C overnight, the precipitates were analyzed by immunoblotting using the indicated antibodies.
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Cysteine-conjugated ubiquitination
is not required for mK3-mediated
down-regulation of HC

To test whether the mK3-induced ubiquitination of HC, like the
MIR1-induced ubiquitination of HC, is dependent on a C residue in the tail of HC, a new Ld mutant was made. The Ld tail has
a single C at position 336 that is conserved among most mouse
HCs. Thus, to test the importance of the tail C residue, a C336S
point mutation was introduced onto a tail K-less Ld template
(Fig. 5 A). WT3 cells were cotransduced with this construct,
termed Ld tail KC-less, and mK3. In the presence of mK3, this

Figure 5. The C residue in the tail of Ld HC is not required for
its ubiquitination and rapid degradation mediated by mK3.
(A) Sequence alignment of the cytoplasmic tails of wt Ld and a
tail KC-less mutant is shown with wt residues in bold and substituted residues in red. (B) Polyubiquitination of Ld HCs in the
cells expressing wt Ld or tail KC-less Ld (±mK3) was examined
by immunoprecipitation of Ld HCs from NP-40 lysates (±endo
H treatment) and immunoblotting for Ub. (C) After incubation
for 24 h with 125 U/ml IFN-γ, cells used in B were pulse labeled
with [35S]Cys/Met for 15 min and chased for the indicated
times. Ld HCs were precipitated, resolved, and visualized as
described in Fig. 1 C. Relative band intensities from the gels
are plotted as a percentage of the intensity at time zero for
each line and are shown beside the gel photos. (D) After incubation with 60 μM MG132 for 2 h, wt Ld HCs or K-less Ld HCs
were precipitated by anti-Ld mAbs and eluted in the presence
or absence of 5% 2ME at pH 8.0. Precipitates then were analyzed by immunoblotting for Ub and Ld HC. Ig bands are indicated by arrows; nonreduced or reduced (non-rd or rd) Ld HC
bands and poly-Ub forms (Ubn) are also indicated.
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KC-less mutant displayed prominent polyubiquitination (Fig.
5 B) and rapid degradation (Fig. 5 C) similar to wt Ld. Thus,
unlike MIR1, a C residue in the HC tail is not required for HC to
be a substrate for mK3-induced ubiquitination and degradation.
To extend this finding and rule out the possibility that C residues in the HC ectodomain are required for mK3 ubiquitination, Ld HC molecules were immunoprecipitated and eluted in
the presence of the thioester-reducing agent 2-mercaptoethanol
(2ME; Fig. 5 D). It should be noted that this is the same treatment used to disrupt the aforementioned ubiquitination of HC
by KSHV protein MIR1 (Cadwell and Coscoy, 2005). Dissociation of the Ig to heavy and light chains (Fig. 5 D, lanes 1–4 vs.
lanes 5–8; indicated by arrows) was an internal control demonstrating the effectiveness of the reduction. However, comparison
of the sample with and without 2ME treatment showed no reduction in the levels of polyubiquitination of wt or K-less Ld.
These combined mutagenesis and chemical findings demonstrate that mK3-induced polyubiquitination does not require
C residues in its HC substrate.
Direct ubiquitination of an S or T
residue on the HC tail is sufﬁcient
to induce rapid degradation

Although it was predicted that they would have insufficient stability, T and S residues have hydroxyl groups that could potentially form ester bonds with Ub (Yu and Kopito, 1999; for
review see Ciechanover and Ben Saadon, 2004). To test this
hypothesis, we made a construct without any of the four potential residues in the tail for Ub conjugation. In total, three Ks,
4 Ss, 1 T, and 1 C in the tail of Ld were mutated (sequence shown in
Fig. 6 A), but the ectodomain and transmembrane portion of wt Ld
were unchanged. The resulting construct, termed KCST-less
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presence of TMB, only the tails of Ld TMB molecules and not
wt Ld were cleaved, as demonstrated by their faster migration
and by blotting with the tail-specific antibody (Fig. 4 B, lanes 7
and 8 vs. lanes 5 and 6). In comparison, wt Ld molecules were
resistant to the TMB treatment (Fig. 4 B, lanes 3 and 4 vs. lanes
1 and 2), indicating a specific and successful TMB cleavage.
More importantly, along with the cleavage of the tail of Ld, the
polyubiquitinated forms of Ld TMB also disappeared (Fig. 4 B,
Ub blot; lanes 7 and 8). Because TMB treatment should not
affect N-terminal polyubiquitination, these experiments along
with the proteinase K experiments clearly defined the HC tail
and not the N terminus as the site of ubiquitination. Importantly,
the same observations were obtained with proteinase K–treated
K-less Ld or tail K-less Ld TMB (unpublished data). Thus, the
clear implication was that ubiquitination of HC by mK3 likely
occurs on non-K residues. Notably, it was recently reported that
the ubiquitination of class I HC induced by MIR1 (also called
kK3), an E3 ligase of Kaposi’s sarcoma-associated herpesvirus
(KSHV), requires a C residue in the cytoplasmic tail of MHC-I
molecules (Cadwell and Coscoy, 2005).
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either hydroxylated or amide amino acid side chains can be directly Ub conjugated by mK3. If this conclusion is true, the
linkage between the hydroxyl side chain of S and the C-terminal
glycine residue of Ub would be an ester bond. To test the existence of this linkage, we compared the stability of the bonds
between Ub and 1K or 1S HCs after exposure to mild alkaline
hydrolysis. It is known that ester bonds are more labile under
these conditions than amide bonds, such as those formed between K residues and Ub (Hershko et al., 1980; Greene, 1981).
Indeed, the ubiquitinated forms of the 1S mutant were undetectable upon incubation with either 1 M hydroxylamine, pH 9.0, or
0.1 M NaOH (Fig. 7 B, top and bottom, respectively). Similarly,
ubiquitinated forms of the 1T(337) mutant were also labile to
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Ld tail, was stably expressed in WT3 cells with and without
mK3. The ubiquitination status as well as the steady-state level
of this Ld mutant was examined. As shown in Fig. 6 B, polyubiquitination of this KCST-less mutant was undetectable compared with wt Ld (left; third and fourth lanes vs. first and second
lanes), although both cell lines expressed similar amounts of
mK3 (Fig. 6 B, right). Concomitant with substantially diminished polyubiquitination, the KCST-less mutant was considerably more stable than wt Ld (Fig. 6 D). To rule out the possibility
that resistance of this mutant to mK3 is the result of impaired
mK3 interaction, we demonstrated that the KCST-less mutant
coimmunoprecipitated with mK3 similar to wt Ld (unpublished
data). Thus, the removal of Ks and all residues with the potential to form ester bonds from the HC tail did not affect its ability
to associate with mK3, only its ability to be ubiquitinated by
mK3. The fact that the polyubiquitined forms disappeared
when KCST residues were removed from only the tail of Ld
and not the rest of the protein corroborated the conclusion that
the tail is the site of ubiquitination. Furthermore, the fact that
the KC-less tail mutant was ubiquitinated by mK3 but the tail
KCST-less was not clearly implicated S and/or T residues in
mK3 function.
We next compared the ability of individual residues to
restore mK3-induced ubiquitination in the KCST-less tail. For
these comparisons, one K (K337), one C (C336), one S (S329),
or one T (T313) was added back to the KCST-less tail mutant of
Ld (Fig. 6 A). These locations were selected because they are
highly conserved among HC alleles. Because the T313 residue
is membrane proximal, whereas the other potential Ub sites
were clustered toward the C terminus of the tail, we also constructed a T337 mutant. Strikingly, a single S or T residue near
the C terminus of the HC tail resulted in substantial polyubiquitination similar to the polyubiquitination of a single K in the
presence of mK3 (Fig. 6, B and C; left). In contrast, the single
C residue near the C terminus or the membrane-proximal T residue only showed very weak or undetectable ubiquitination.
These findings suggested that hydoxylated amino acids (either
S or T) can be sites of Ub conjugation but that location toward
the C terminus of the tail is critical (Fig. 6, B and C; left).
Importantly, similar levels of mK3 were expressed in these
cells (Fig. 6, B and C; right). Consistent with Ub conjugation,
the S329, T337, and K337 mutants were more rapidly degraded
in mK3-expressing cells compared with the KCST-less tail
mutant (Fig. 6 D).
The fact that the 1S or 1T (337) tail was polyubiquitinated
and degraded in the absence of K residues largely ruled out the
likelihood that S or T residues are required for other modifications, such as phosphorylation (Meusser and Sommer, 2004).
However, the possibility remained that the observed ubiquitination of a K-less ERAD substrate might be the result of the ubiquitination of adaptor proteins (Yu and Kopito, 1999; Hassink
et al., 2006). To definitively demonstrate that the HC is directly
ubiquitinated, precipitates of the 1K or 1S Ld proteins were
boiled in 0.5% SDS and 10 mM DTT and reprecipitated with
antibody to denatured Ld. As shown in Fig. 7 A, polyubiquitination of 1K or 1S tails was unaffected by denaturation, whereas
β2m assembly was eliminated. This result demonstrated that

Figure 6. Ubiquitination of Ld by mK3 can occur on either S, T, or K residues on the tail of Ld. (A) Nomenclature and sequence alignment of the
cytoplasmic tails of Ld tail mutants are shown with original wt residues
in bold, substituted residues in red, and added back residues in blue.
(B) WT3 cells stably coexpressing mK3 and one of the Ld tail mutants were
NP-40 lysed. After precipitation of Ld, precipitates were immunoblotted for
Ub and Ld (left). In the right panel, the β-actin and mK3 blots were included
to show that a similar amount of input lysate of each line was used for
immunoprecipitation and a similar amount of mK3 was expressed in each
line. (C) Cells coexpressing mK3 and one of the Ld tail mutants 1K, 1T(313),
or 1T(337) were lysed, immunoprecipitated, and blotted as described in B.
(D) After incubation for 24 h with 125 U/ml IFN-γ, cells used in B and C
were pulse labeled with [35S]Cys/Met for 15 min and chased for the indicated times. Ld HCs were precipitated, resolved, and visualized as described in Fig. 1 C. Relative band intensities from the gels are plotted as a
percentage of the intensity at time zero for each line and are shown beneath the gel photos.
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mild alkaline treatment (unpublished data). As expected, the 1K
mutant was stable to treatment with either reagent (Fig. 7 B).
These data strongly support the hypothesis that mK3 is capable
of facilitating the novel conjugation of ubiquitination to an S or
T residue in the cytoplasmic tail of Ld via an ester linkage.

Discussion
The mechanism of how substrates are retrotranslocated or dislocated from ER membrane is still poorly understood. It is
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Figure 7. Evidence for the direct conjugation of Ub to an S residue of the
Ld tail mediated by mK3. (A) Ld HCs were precipitated by anti-Ld mAbs
30-5-7 and 64-3-7 from NP-40 lysates of the cells expressing Ld tail 1K or
Ld tail 1S mutant (±mK3). After incubation in 0.5% SDS and 10 mM DTT
at room temperature for 10 min and boiling for 10 min, part of the elutes
were reprecipitated by the conformation-independent anti-Ld mAb 64-3-7.
Note that for this experiment, similar amounts of Ld were loaded for each
sample. The ﬁrst and second precipitates were immunoblotted for Ub, Ld,
and β2m. Ub-conjugated Ld forms (Ubn-Ld) and unconjugated Ld HCs are
indicated. Nonspeciﬁc staining of antibody heavy chain (Ig HC) is also
indicated. (B) After incubation with 30 μM MG132 for 3 h, the cells stably
expressing Ld tail KCST-less, Ld tail 1K, or Ld tail 1S (+mK3) were lysed with
NP-40. After precipitation of Ld, the precipitates were incubated with or
without (−/+) 1 M sodium hydroxylamine, pH 9, for 4 h at 37°C (top) or
with or without (−/+) 0.1 M NaOH for 2 h at 37°C (bottom). Then, the
precipitates were subjected to SDS-PAGE and immunoblotting for Ub and
Ld. Ub-conjugated Ld forms (Ub2-Ld or Ub3-Ld) and unconjugated Ld HCs are
indicated. Because NaOH-treated samples were reduced by 2.5% 2ME
before loading for SDS-PAGE, unconjugated and conjugated Ld HCs
migrate slower than nonreduced sodium hydroxylamine–treated samples,
and a disassociated Ig HC band can be seen in the blot.

known that ubiquitination plays a crucial role in this action, but
when it happens and whether a direct Ub conjugation to the
substrate is required are not clear. For soluble lumenal substrates, mutations in the ubiquitination system result in substrates accumulating in the ER (Jarosch et al., 2002b), suggesting
that the ubiquitination of substrates is required for their dislocation.
However, because lumenal substrates are separated from the
ubiquitination apparatus by a membrane, the substrate ubiquitination obviously does not initiate their dislocation. On the
other hand, for integral membrane proteins, one would think
that its cytosolic portion might be the most convenient site for
Ub conjugation, which could subsequently recruit Ub-binding
protein and the ATPase complex required for complete extraction of the substrate. However, for several typical type I membrane protein substrates, such as orphan subunit TCRα and
MHC-I HC in the presence of US2 or US11, K residues in the
substrate’s tail are dispensable for their dislocation (Shamu
et al., 1999; Yu and Kopito, 1999; Furman et al., 2003). In the
specific case of US2-induced ERAD of HC, internal K residues
were found to be required for dislocation (Hassink et al., 2006).
However, for the other aforementioned ERAD substrates, the
replacement of all internal Ks on these ERAD substrates did
not affect their dislocation, suggesting a non-K–mediated form
of ubiquitination.
One possible explanation is N-terminal ubiquitination, in
which the first Ub moiety is fused linearly to the α-NH2 group
of the substrate N terminus. This type of ubiquitination has been
demonstrated for >12 proteins and, thus, provides an alternative mode of ubiquitination that may be particularly important
for the regulation of proteins that have no accessible K residues
(Ciechanover, 2005). In ERAD, however, such a process has not
been well established, especially for soluble lumenal substrates
or type I membrane substrates with their N termini in the ER
lumen. For these types of substrates, a partial dislocation of
their N termini to the cytosolic side is presumably required before
the addition of Ub because all of the functional ubiquitination
components are located in the cytosol. Recently, Hassink et al.
(2006) attached Ub to the N terminus of wt and K-less HCs and
found that it did not accelerate their dislocation in the presence
of US11. This finding suggests that N-terminal ubiquitination
does not play a role in US11-initiated extraction of HCs from
the ER membrane.
An alternative explanation for the dislocation of K-less
membrane proteins is that an adaptor protein is ubiquitinated
instead of direct ubiquitination of the substrate. Ubiquitination on an adaptor could link the associated substrate with the
extraction machinery, resulting in complete extraction of the
substrate. Interestingly, this mechanism is supported by recent
studies of the dislocation of K-less HC by US11 (Hassink et al.,
2006). However, the ultimate confirmation for such a model will
have to await identification of the ubiquitinated adaptor protein.
An important consideration regarding conclusions using K-less
substrates is whether ubiquitination can occur via non-K residues.
For example, it has been reported that MIR1 ligase (also called
kK3) of KSHV can ubiquitinate C residues in the HC tail via
thioester bonds, thus targeting it for degradation through an
endocytic–lysosome pathway (Cadwell and Coscoy, 2005).
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as well as K residues reflects a unique, direct interaction of mK3
with the HC substrate or, alternatively, may involve distinct
cellular components such as E2 conjugation enzymes or other
necessary cofactors.
The ubiquitination pattern induced by mK3 is somewhat
surprising. Even when the HC substrate has a wt tail, the Ub2
and Ub3 forms are predominant. It is noteworthy that Boname
and Stevenson (2001) also detected HCs with predominantly
Ub2 and Ub3 forms and few, if any, higher than Ub3 in the presence of mK3. Because the proteasome requires Ub4 to provide
sufficient avidity for binding substrates for degradation (Thrower
et al., 2000), we have considered the notion that multimers
higher than Ub3 may be unstable and, thus, difficult to detect in
steady-state assays. Indeed, when proteasome inhibitor was
used, Ub4 and Ub5 multimers can be detected (Figs. 2 B and
5 D). However, proteasome inhibitors result in only modest increases in forms higher than Ub3, which is likely the result of
the fact that the 2–3-h treatment does not appreciably affect
steady-state levels of ubiquitination. Interestingly, tails containing a single S, T, or K residue displayed an even greater predominance of Ub2 forms, although Ub3 and higher multimers
show up on longer exposure. In any case, HC tails with only one
S, T, or K residue are viable ERAD substrates in the presence of
mK3, implying they are polyubiquitinated to Ub4. It is also interesting that in the presence of mK3, the minimum ubiquitination forms of HCs are Ub2, regardless of whether it is a wt
or tail 1S, 1T, or 1K substrate. This may imply that mK3 facilitates the transfer of a premade Ub2 or Ub3 chain from cognate
E2 to the substrates.
The findings reported in this study clarify the molecular
basis of mK3 substrate specificity. Our previous study failed to
detect an HC-specific tail sequence required for mK3 interaction (Wang et al., 2004). The finding of alternative sites for
mK3-mediated ubiquitination reported here is consistent with
this conclusion. Interestingly, the primary binding partner for
mK3 is TAP, the transporter responsible for dislocating proteasome-processed peptides into the ER lumen, and a mutagenesis
study showed that it is the C terminus of mK3 that binds TAP
(Wang et al., 2004). Most class I HC alleles require a physical
association with TAP after assembly with β2m and before the
binding of high affinity peptide ligands (Grandea et al., 2000).
These combined findings suggest a proximity model whereby
the specific recognition of HC by mK3 is achieved by TAP
binding to the mK3 C terminus, which then orients the N-terminal
mK3 RING domain such that it can only interact with the HC
tail. Thus, TAP is the key mK3 adaptor protein juxtaposing the
mK3 RING domain with the HC tail to confer substrate specificity. The demonstration here of the importance of the location
of ubiquitination sites within the tail lends strong support to this
proximity model. This model provides a viable general strategy
for allowing E3s to maintain their requisite substrate specificity
while facilitating the ubiquitination of a highly polymorphic
substrate such as HC. With the required juxtaposition of mK3
RING and HC tail, the necessary cellular ubiquitination components, including an appropriate E2, can then be recruited, resulting in ubiquitination of the HC tail. This core ER membrane
complex centered on mK3 can also include Derlin1, although
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In the case of mK3-induced HC ubiquitination and degradation, we previously showed that the substitution of all Ks in
the tail of MHC-I HC did not affect the ubiquitination status or
the degradation of these molecules (Wang et al., 2005). Nevertheless, deletion of the tail abolished the ubiquitination of HC,
leading to its stabilization in the ER (Wang et al., 2005). Indeed,
a similar phenotype has also been found in the US11-induced
turnover of MHC-I HC (Story et al., 1999; Barel et al., 2003).
Our erroneous explanation for these observations was that the
tail of HC is required for the initiation of dislocation but not for
direct tail ubiquitination.
In the present study, a complete K-less Ld and a K-less
Ub/K-less Ld fusion protein were found to be polyubiquitinated
and rapidly degraded in the presence of mK3. This finding
suggested that neither lumenal Ks nor an α-NH2 group of the
N terminus of HC are essential Ub conjugation sites required by
mK3. More importantly, we demonstrated that polyubiquitinated HCs become undetectable when the tail was removed by
proteinase K digestion or via an engineered TMB cleavage site.
These findings demonstrated that the HC tail is the site of ubiquitination. Of note, these observations were also made with wt
Ld molecules, demonstrating that it is a normal process used by
native protein and not merely a forced pathway used by substrates having no available Ks. Furthermore, we found that
mutations of all K and C residues of the Ld tail did not affect
mK3-induced ERAD. However, the additional removal of
S and T residues in the tail abolished mK3-induced polyubiquitination and stabilized the HC. These findings suggested that
one or both of the hydroxylated amino acids were sufficient
for ubiquitination.
To extend these observations using a better defined approach, individual K, C, S, and T residues were reintroduced
into Ld with a KCST-less tail. Remarkably, HCs with tails having only one S, T(337), or K were polyubiquitinated and were
susceptible to ERAD in the presence of mK3. However, location was found to be important in that all efficacious ubiquitination sites were clustered toward the C terminus of the HC tail.
In contrast, a tail with a membrane-proximal T residue displayed no detectable ubiquitination. S and T residues are potential phosphorylation sites that could be required to recruit a
putative HC-associated protein that is ubiquitinated. To demonstrate that HC is itself ubiquitinated, HCs with single S or K in
their tails were denatured and reprecipitated with a class I–
specific mAb. In both cases, ubiquitinated HCs were still detected after treatment, demonstrating that Ub moieties can be
covalently attached to either S, T, or K residues in the HC tail in
the presence of mK3. In strong support of this conclusion, 2-ME
that specifically disrupts thioester bonds formed with C residues had no effect on the Ub conjugation to S or K residues of
the HC tail in the presence of mK3. Alternatively, mild alkaline
hydrolysis with sodium hydroxylamine or NaOH, reagents that
are effective in cleaving ester bonds and not amide bonds, removed detectable mK3-mediated ubiquitination via S or T but
not K residues. Thus, in the presence of mK3, ester bonds are
formed that covalently link Ub to S or T residues in the tail of
the HC substrate, thereby defining a novel form of ubiquitination.
It will be interesting to determine whether the ability to use S and T
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Materials and methods
Cell lines and ﬂow cytometry
Mouse B6/WT3 (WT3, H-2b) cells were described previously (Wang et al.,
2004). 293T cells (DuBridge et al., 1987) were used for the production of ecotropic retrovirus. All cells were maintained in complete RPMI 1640 with 10%
FCS (HyClone) as described previously (Lybarger et al., 2003). Retroviruscontaining supernatants were produced using the Vpack vector system
(Stratagene) with transient transfection of 293T cells. Cells transduced by
the pMIN-containing virus were enriched by geneticine selection, whereas
GFP+ cells from pMIG-transduced lines were enriched by cell sorting.
Where indicated, cells were cultured for 24 h with 125 U/ml of mouse
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IFN-γ (Biosource International) and for 2–3 h with 30–60 μM of the proteasome inhibitor MG132 (Boston Biochem) or 5 μM clasto-lactacystin β-lactone
(Calbiochem) before harvesting with trypsin-EDTA. All ﬂow cytometric
analyses were performed as previously described (Lybarger et al., 2003).
DNA constructs
Two retroviral expression vectors, pMSCV.IRES.GFP (pMIG) and pMSCV.
IRES.neo (pMIN; Wang et al., 2004), were used to express mK3 and Ld
constructs, respectively. mK3 sequence was obtained by PCR ampliﬁcation
of the K3 gene from a γHV68 subclone (Virgin et al., 1997). Both mK3
and Ld mutants were generated by site-directed mutagenesis (Stratagene).
Ub/Ld fusion constructs were made by overlapping PCR, wherein the uncleavable wt and K-less Ub sequences (wt Ub and K-less Ub, with replacement of glycine 76 to valine) were PCR ampliﬁed from the constructs
pLZRS-Ub G76V-HLA.A2 and pLZRS-UbK®R G76V-HLA.A2 (Hassink et al.,
2006). The correct sequences for all of the constructs were conﬁrmed by
DNA sequencing.
Antibodies
Rabbit anti-mK3, Ub antibodies, β-actin (AC-74) antibodies, and mAbs
30-5-7 and 64-3-7 to folded and open forms of MHC class I Ld were previously described (Lybarger et al., 2003). Antibodies (Ra20873) to the cytoplasmic tail of Ld were produced in rabbits immunized with the cytoplasmic
tail peptide (Smith et al., 1995).
Immunoprecipitation and immunoblots
Immunoprecipitation and immunoblotting were conducted as previously
described (Lybarger et al., 2003). In brief, cells were lysed in PBS buffer
containing 1% NP-40, 20 mM iodoacetamide (Sigma-Aldrich), and Complete mini protease inhibitors (Roche) or 0.4 mM PMSF (Sigma-Aldrich).
Postnuclear lysates were incubated with protein A–Sepharose beads
(Sigma-Aldrich) and antibodies. After washing beads four times with PBS/
iodoacetamide buffer containing 0.15% NP-40, immunoprecipitates were
eluted from protein A by boiling for 3 min in lithium dodecyl sulfate sample
buffer (Invitrogen). For endo H treatment, immunoprecipitates were eluted
in 10 mM Tris-HCl, pH 6.8, with 0.5% SDS, and the elutes then were mixed
with an equal volume of 100 mM sodium acetate, pH 5.4, and incubated
with 1 μU endo H (MP Biomedicals) at 37°C for 2 h. Immunoblotting was
performed after SDS-PAGE separation of precipitated proteins or cell lysates
as previously described (Yu et al., 2002). Speciﬁc proteins were visualized
by chemiluminescence using the ECL system (GE Healthcare).
Metabolic labeling and pulse chase
After 30 min of preincubation in Cys- and Met-free medium (MEM-Earle’s
with 5% dialyzed FCS), cells were pulse labeled with Express [35S]Cys/
Met labeling mix (Perkin Elmer) at 150 μCi/ml for 10–15 min. Chase was
initiated by the addition of an excess of unlabeled Cys/Met (5 mM each).
Immunoprecipitation was performed as described in the previous section.
Samples were subjected to SDS-PAGE, and gels were treated with Amplify
(GE Healthcare), dried, and exposed to BioMax-MR ﬁlm (Kodak).
ER isolation and proteinase K digestion
Cells were incubated in cold hypotonic extraction buffer containing 10 mM
Hepes, pH 7.8, 25 mM KCl, and 1 mM EGTA for 20 min and were resuspended in isotonic extraction buffer containing 10 mM Hepes, pH 7.8,
250 mM sucrose, 25 mM KCl, and 1 mM EGTA before they were broken
with 20 strokes of Dounce homogenizer on ice. The homogenate was
then subjected to serial centrifugations at 1,000 g for 10 min, 10,000 g for
10 min, and 100,000 g for 60 min, which were all performed at 4°C. The
100,000 g pellet was resuspended in PBS with 20 mM iodoacetamide.
Two aliquots of the suspension were incubated on ice with or without
10 μg/ml proteinase K (Invitrogen) for 20 min. After the digestion was
stopped by 2 mM PMSF, NP-40 was added to a ﬁnal concentration of 1% to
disrupt the membranes. PMSF and NP-40 were also added into 100,000 g
supernatant fractions. Subsequent immunoprecipitation and immunoblotting were performed as described above in the Immunoprecipitation
and immunoblots section.
Sodium hydroxylamine and sodium hydroxide treatment
Immunoprecipitates were boiled in 0.5% SDS for 3 min followed by incubation in either 1 M sodium hydroxylamine, pH 9, for 4 h at 37°C or sodium
hydroxide (0.1 M NaOH) for 2 h at 37°C. Mock-treated samples were incubated with PBS. Before SDS-PAGE analysis, the sodium hydroxylamine–
treated samples were dialyzed against PBS overnight at 4°C using 3500
MWCO MINI dialysis units (Pierce Chemical Co.).
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it appears to have a redundant function (Wang et al., 2006; and
unpublished data). ATPase p97 is also recruited to this mK3 core
membrane complex, and this association clearly has an impact
on mK3-induced ERAD (Wang et al., 2006).
The aforementioned findings suggest that the viral mK3
ligase assimilates a core membrane complex in mouse cells
similar to ERAD complexes described in yeast. In this context,
it is interesting to compare properties and outstanding questions
regarding the mK3 membrane complex with the aforementioned
yeast Doa10p (ERAD-C) and Hrd1p (ERAD-L) complexes
(Vashist and Ng, 2004; Carvalho et al., 2006; Denic et al., 2006).
HC tail ubiquitination by mK3 suggests that it mimics an
ERAD-C pathway induced by substrates with a cytosolic lesion
(Vashist and Ng, 2004; Carvalho et al., 2006), and ERAD-C
does not require Der1p, as mK3 does not require the Der1p homologue Derlin1 (Wang et al., 2006; and unpublished data).
Models such as ERAD-C and the mK3 model would not require
the partial dislocation of substrate before ubiquitination, and
polyubiquitination of the tail could be the initiating signal for
dislocation. It is intriguing to speculate that mK3 may also be a
component of the dislocation channel, if indeed one is required
for this pathway. In the context of an ERAD-L–like model, it is
unclear whether molecular interactions are required in the ER
lumen to promote substrate dislocation. Although mK3 has only
12 amino acids in the ER lumen, it could disrupt transmembrane interactions between proteins within the core membrane
complex, and this disruption could induce ER protein folding
sensors (chaperones) to bind the ectodomain of HC and facilitate dislocation. Defining the molecular composition of the dislocation pore and the signals that initiate substrate dislocation
are key questions for any of these Ub ligase–induced membrane
complexes involved in distinct ERAD pathways. In any case,
findings with viral ligase mK3 suggest that it can assemble a
unique core ER membrane complex that specifically detects
MHC class I HCs and targets them for ERAD.
In summary, we report that the mK3 ligase directly ubiquitinates its HC substrate at tail S, T, or K residues. This observation obviates the need for the partial dislocation of HC before
ubiquitination, suggesting a vectorial exit from the ER. It will
be interesting to determine whether other ERAD pathways involving transmembrane protein substrates might also involve tail
ubiquitination using non-K residues. Furthermore, the fact that
mK3 has numerous viral (including MIR1) and cellular homologues makes it attractive to speculate that other ubiquitinationregulated processes use similar nonconventional methods of
Ub conjugation.
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